These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28334173)

  • 1. A review of connectivity map and computational approaches in pharmacogenomics.
    Musa A; Ghoraie LS; Zhang SD; Glazko G; Yli-Harja O; Dehmer M; Haibe-Kains B; Emmert-Streib F
    Brief Bioinform; 2017 Sep; 18(5):903. PubMed ID: 28334173
    [No Abstract]   [Full Text] [Related]  

  • 2. Querying genomic databases: refining the connectivity map.
    Segal MR; Xiong H; Bengtsson H; Bourgon R; Gentleman R
    Stat Appl Genet Mol Biol; 2012 Jan; 11(2):. PubMed ID: 22499690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lay perspective on pharmacogenomics: a literature review.
    Nielsen LF; Møldrup C
    Per Med; 2006 Aug; 3(3):311-316. PubMed ID: 29788651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic databases in pharmacogenomics: the Frequency of Inherited Disorders Database (FINDbase).
    Georgitsi M; Patrinos GP
    Methods Mol Biol; 2013; 1015():321-36. PubMed ID: 23824866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical, social and legal implications of pharmacogenomics: a critical review.
    Moldrup C
    Community Genet; 2001; 4(4):204-14. PubMed ID: 12751484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomics in the nursing literature: an integrative review.
    Knisely MR; Carpenter JS; Von Ah D
    Nurs Outlook; 2014; 62(4):285-96. PubMed ID: 24863878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we keep on? Looking into pharmacogenomics of ADHD in adulthood from a different perspective.
    Rovaris DL; Mota NR; da Silva BS; Girardi P; Victor MM; Grevet EH; Bau CH; Contini V
    Pharmacogenomics; 2014 Jul; 15(10):1365-81. PubMed ID: 25155937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenomics: historical perspective and current status.
    Charlab R; Zhang L
    Methods Mol Biol; 2013; 1015():3-22. PubMed ID: 23824846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality by design (QbD) approach of pharmacogenomics in drug designing and formulation development for optimization of drug delivery systems.
    Gupta S; Jhawat V
    J Control Release; 2017 Jan; 245():15-26. PubMed ID: 27871989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Academic and professional pharmacy education: a pharmacogenomics certificate training program.
    Kisor DF; Bright DR; Chen J; Smith TR
    Per Med; 2015 Nov; 12(6):563-573. PubMed ID: 29750615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A survey on the awareness and attitude of pharmacists and doctors towards the application of pharmacogenomics and its challenges in Qatar.
    Elewa H; Alkhiyami D; Alsahan D; Abdel-Aziz A
    J Eval Clin Pract; 2015 Aug; 21(4):703-9. PubMed ID: 25929423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized pharmacogenomics profiling using whole-genome sequencing.
    Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
    Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery.
    Yan Q
    Methods Mol Biol; 2008; 448():1-19. PubMed ID: 18370227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacometabolomics informs Pharmacogenomics.
    Neavin D; Kaddurah-Daouk R; Weinshilboum R
    Metabolomics; 2016 Jul; 12(7):. PubMed ID: 27516730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and opportunities in implementing pharmacogenomics testing in the clinics.
    Wisler JR; Wisler JW; Bansal S; Marsh CB
    Per Med; 2012 Aug; 9(6):609-619. PubMed ID: 29768798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Golden Helix Pharmacogenomics Days: educational activities on pharmacogenomics and personalized medicine.
    Squassina A; Severino G; Grech G; Fenech A; Borg J; Patrinos GP
    Pharmacogenomics; 2012 Apr; 13(5):525-8. PubMed ID: 22462744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics and pharmacogenomics as tools in cancer therapy.
    Rodríguez-Vicente AE; Lumbreras E; Hernández JM; Martín M; Calles A; Otín CL; Algarra SM; Páez D; Taron M
    Drug Metab Pers Ther; 2016 Mar; 31(1):25-34. PubMed ID: 26863347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of pharmacogenomics for anesthesia providers.
    Ama T; Bounmythavong S; Blaze J; Weismann M; Marienau MS; Nicholson WT
    AANA J; 2010 Oct; 78(5):393-9. PubMed ID: 21067087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic evaluation of connectivity map for disease indications.
    Cheng J; Yang L; Kumar V; Agarwal P
    Genome Med; 2014; 6(12):540. PubMed ID: 25606058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.